Svs Pharma Distributor Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -100.00%
(FY 2023)
- Profit 88.00%
(FY 2023)
- Ebitda -106.11%
(FY 2023)
- Net Worth -9.54%
(FY 2023)
- Total Assets -61.93%
(FY 2023)
About Svs Pharma Distributor
The Corporate was formerly known as Aksn Surgicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Prabhavathi Dumpa and Dumpa Reddy serve as directors at the Company.
- CIN/LLPIN
U85100TG2020PTC140543
- Company No.
140543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Svs Pharma Distributor?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhavathi Dumpa  | Director | 22-May-2021 | Current |
| Dumpa Reddy | Director | 22-May-2021 | Current |
Financial Performance of Svs Pharma Distributor.
Svs Pharma Distributor Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 88% increase in profit. The company's net worth dipped by a decrease of 9.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svs Pharma Distributor?
In 2023, Svs Pharma Distributor had a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Svs Med Tech (Mh) Private LimitedActive 3 years 8 monthsPrabhavathi Dumpa and Dumpa Reddy are mutual person
- Svs Facility Management Services Private LimitedActive 9 years 21 days
Prabhavathi Dumpa and Dumpa Reddy are mutual person
- Idyllic Facilities Private LimitedActive 5 years 2 months
Prabhavathi Dumpa and Dumpa Reddy are mutual person
- Healife Health Care Private LimitedActive 3 years 7 months
Prabhavathi Dumpa and Dumpa Reddy are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Svs Pharma Distributor?
Svs Pharma Distributor has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svs Pharma Distributor, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svs Pharma Distributor's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
